Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce the font size Increase the font size  
 
 

Our activities

Contact us

Sanofi

To get more information about our products,
please call (91-22) 28032000

Content :

Sanofi-Synthelabo (India) Private Limited: Product range

Sanofi India provides medicines for the treatment of patients in several therapeutic areas: cardiology, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines.

Healthcare professionals seeking abbreviated prescribing information of the prescription product portfolio of Sanofi-Synthelabo (India) Private Ltd. please click here

 
List of direct links to sections :

Thrombosis

  • Plavix® (clopidogrel hydrogen sulphate)

Cardiovascular

  • Adenocor IV® (adenosine)
  • Cordarone® (amiodarone hydrochloride)
  • Primacor® IV (milrinone lactate)

Oncology

  • Fasturtec® (rasburicase)
  • Jevtana®
  • Fludara® Injection

Central Nervous System

  • Depakote® (divalproex sodium Delayed Release)
  • Depakote® XR (divalproex sodium Extended Release)
  • Solian® (amisulpride (50/100/200/400) mg)
  • Stilnoct® (zolpidem tartrate)
  • Valparin® Chrono (sodium valproate, valproic acid)
  • Valparin® Syrup (sodium valproate)
  • Vinlep™ (oxcarbazepine)

Internal Medicine

  • Enterogermina® Oral Suspension (bacillus clausii spores)
  • Enterogermina® Capsules (bacillus clausii spores)
  • Lactacyd® (Lactic acid and Lactoserum)
  • Myoril® (thiocolchicoside)

Updated June 24, 2015

Module :

Medical Information / Pharmacovigilance

A key activity of Sanofi is to provide updated medical information on its products, to healthcare professionals, which is in compliance with Indian regulations. All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters.
For medical information, contact:
medinfo.india@sanofi.com / Tel no. (022) 28032000 , Extension 2063

Sanofi also ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide, as pharmacovigilance remains a key activity in the assessment of the therapeutic value of products.
For Reporting adverse events, contact:
PV.india@sanofi.com / Tel no. (022) 28032000 , Extension 2055